INBX logo

Inhibrx Biosciences (INBX) Cash From Investing

Annual CFI

-$4.59 M
-$3.91 M-569.53%

December 31, 2023

Summary

Performance

1-Year Change

-569.53%

3-Year Change

-236.73%

5-Year Change

-221.41%

15-Year Change

-242.76%

INBX Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

36.2%
INBX annual cash flow from investing activities is higher than 36.2% of companies in Healthcare sector

High & Low

All-time High

-$686.00 K

3-Year Low

-$4.59 M
INBX annual cash flow from investing activities is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
INBX previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 28, 2025
INBX next annual earnings announcement is scheduled for Feb 28, 2025

OtherINBXcash flowmetrics:

Annual CFF

$201.96 M
INBX annual cash flow from financing activities is $201.96 million

Annual CFO

-$193.31 M
INBX annual cash flow from operations is -$193.31 million

Annual FCF

-$197.90 M
INBX annual free cash flow is -$197.90 million

Annual CAPEX

$4.59 M
INBX annual capital expenditures is $4.59 million

Quarterly CFI

-$247.00 K
+$968.00 K+79.67%

September 30, 2024

Summary

Performance

3-Month Change

+79.67%

1-Year Change

+79.67%

3-Year Change

-973.91%

5-Year Change

-973.91%

INBX Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

39.52%
INBX quarterly cash flow from investing activities is higher than 39.52% of companies in Healthcare sector

High & Low

All-time High

$20.00 K
INBX quarterly cash flow from investing activities is currently -1335.00% below its historical high of $20.00 thousand

3-Year Low

-$3.44 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
INBX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
INBX next earnings announcement is scheduled for Feb 28, 2025

OtherINBXcash flowmetrics:

Quarterly CFF

$0.00
INBX quarterly cash flow from financing activities is $0.00

Quarterly CFO

-$30.28 M
INBX quarterly cash flow from operations is -$30.28 million

Quarterly FCF

-$30.53 M
INBX quarterly free cash flow is -$30.53 million

Quarterly CAPEX

-
INBX quarterly capital expenditures value is unknown

TTM CFI

-$6.02 M
+$564.00 K+8.56%

September 30, 2024

Summary

Performance

3-Month Change

+8.56%

1-Year Change

+8.56%

3-Year Change

-917.4%

5-Year Change

-917.4%

INBX TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

36.23%
INBX TTM cash flow from investing activities is higher than 36.23% of companies in Healthcare sector

High & Low

All-time High

-$75.00 K

3-Year Low

-$6.59 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
INBX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
INBX next earnings announcement is scheduled for Feb 28, 2025

OtherINBXcash flowmetrics:

TTM CFF

$4.18 M
INBX TTM cash flow from financing activities is $4.18 million

TTM CFO

-$143.21 M
INBX TTM cash flow from operations is -$143.21 million

TTM FCF

-$149.23 M
INBX TTM free cash flow is -$149.23 million

TTM CAPEX

-
INBX TTM capital expenditures value is unknown

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

INBX Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-569.5%+79.7%+8.6%
3 y3 years-236.7%-973.9%-917.4%
5 y5 years-221.4%-973.9%-917.4%

INBX Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-569.5%at low-1335.0%+92.8%-926.1%+8.6%
5 y5-year-569.5%at low-1335.0%+92.8%-926.1%+8.6%
alltimeall time-569.5%at low-1335.0%+92.8%-7930.7%+8.6%

Inhibrx Biosciences Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2024
-
-$247.00 K(-79.7%)
-$6.02 M(-8.6%)
Jun 2024
-
-$1.22 M(+8.6%)
-$6.59 M(+15.8%)
Mar 2024
-
-$1.12 M(-67.5%)
-$5.69 M(+23.9%)
Dec 2023
-$4.59 M(+569.5%)
-$3.44 M(+324.4%)
-$4.59 M(+223.9%)
Sep 2023
-
-$811.00 K(+155.8%)
-$1.42 M(+141.6%)
Jun 2023
-
-$317.00 K(+1278.3%)
-$587.00 K(-0.8%)
Mar 2023
-
-$23.00 K(-91.4%)
-$592.00 K(-13.7%)
Dec 2022
-$686.00 K(-15.2%)
-$267.00 K(-1435.0%)
-$686.00 K(0.0%)
Sep 2022
-
$20.00 K(-106.2%)
-$686.00 K(-21.6%)
Jun 2022
-
-$322.00 K(+175.2%)
-$875.00 K(-4.1%)
Mar 2022
-
-$117.00 K(-56.2%)
-$912.00 K(+12.7%)
Dec 2021
-$809.00 K
-$267.00 K(+58.0%)
-$809.00 K(-29.9%)
Sep 2021
-
-$169.00 K(-52.9%)
-$1.15 M(-10.1%)
DateAnnualQuarterlyTTM
Jun 2021
-
-$359.00 K(+2464.3%)
-$1.28 M(-0.2%)
Mar 2021
-
-$14.00 K(-97.7%)
-$1.29 M(-5.6%)
Dec 2020
-$1.36 M(-24.6%)
-$612.00 K(+104.7%)
-$1.36 M(+25.5%)
Sep 2020
-
-$299.00 K(-17.4%)
-$1.09 M(-27.5%)
Jun 2020
-
-$362.00 K(+297.8%)
-$1.50 M(-17.8%)
Mar 2020
-
-$91.00 K(-72.8%)
-$1.82 M(+0.8%)
Dec 2019
-$1.81 M(+26.7%)
-$335.00 K(-52.9%)
-$1.81 M(+22.7%)
Sep 2019
-
-$711.00 K(+3.5%)
-$1.48 M(+93.1%)
Jun 2019
-
-$687.00 K(+792.2%)
-$764.00 K(+29.9%)
Mar 2019
-
-$77.00 K(-84.9%)
-$588.00 K(+0.3%)
Dec 2018
-$1.43 M(+6.6%)
-
-
Jun 2018
-
-$511.00 K(+581.3%)
-$586.00 K(+681.3%)
Mar 2018
-
-$75.00 K
-$75.00 K
Dec 2017
-$1.34 M
-
-

FAQ

  • What is Inhibrx Biosciences annual cash flow from investing activities?
  • What is the all time high annual CFI for Inhibrx Biosciences?
  • What is Inhibrx Biosciences annual CFI year-on-year change?
  • What is Inhibrx Biosciences quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Inhibrx Biosciences?
  • What is Inhibrx Biosciences quarterly CFI year-on-year change?
  • What is Inhibrx Biosciences TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Inhibrx Biosciences?
  • What is Inhibrx Biosciences TTM CFI year-on-year change?

What is Inhibrx Biosciences annual cash flow from investing activities?

The current annual CFI of INBX is -$4.59 M

What is the all time high annual CFI for Inhibrx Biosciences?

Inhibrx Biosciences all-time high annual cash flow from investing activities is -$686.00 K

What is Inhibrx Biosciences annual CFI year-on-year change?

Over the past year, INBX annual cash flow from investing activities has changed by -$3.91 M (-569.53%)

What is Inhibrx Biosciences quarterly cash flow from investing activities?

The current quarterly CFI of INBX is -$247.00 K

What is the all time high quarterly CFI for Inhibrx Biosciences?

Inhibrx Biosciences all-time high quarterly cash flow from investing activities is $20.00 K

What is Inhibrx Biosciences quarterly CFI year-on-year change?

Over the past year, INBX quarterly cash flow from investing activities has changed by +$968.00 K (+79.67%)

What is Inhibrx Biosciences TTM cash flow from investing activities?

The current TTM CFI of INBX is -$6.02 M

What is the all time high TTM CFI for Inhibrx Biosciences?

Inhibrx Biosciences all-time high TTM cash flow from investing activities is -$75.00 K

What is Inhibrx Biosciences TTM CFI year-on-year change?

Over the past year, INBX TTM cash flow from investing activities has changed by +$564.00 K (+8.56%)